A/Prof Peter Hamblin
Clinical (Associate Professor)
Department of Medicine
100 Scholarly works
1 Projects
HIGHLIGHTS
2026
Journal article
Higher HbA1c Following Younger Age of Transfer From Pediatric to Adult Type 1 Diabetes Services: Data From the Australasian Diabetes Data Network (ADDN) Registry
DOI: 10.2337/dc25-30262026
Journal article
Shifts in Incident Glucose Lowering Drug Initiation in Type 2 Diabetes From 2014 to 2024: A Population-Based Study.
DOI: 10.1111/dom.710472026
Journal article
Comparative effectiveness of glucose monitoring methods and glycaemic control in patients with type 2 diabetes: An umbrella review
DOI: 10.1111/dom.704012026
Journal article
Perceived benefits and drawbacks of cultivating self-compassion among women diagnosed with Gestational Diabetes Mellitus (GDM)
DOI: 10.1016/j.midw.2025.1046692025
Journal article
Perinatal Outcomes of Type 1 and Type 2 Diabetes in Pregnancy: A 10-Year Single-Centre Cohort Study
DOI: 10.3390/diabetology61201512025
Journal article
The growing range of complications of diabetes mellitus
DOI: 10.1016/j.tem.2024.12.0062021
Research grants (ARC, NHMRC, MRFF)
Platform to Enhance Prostate Cancer Shared Care Integration (PEPSI)
RECENT SCHOLARLY WORKS
2025
Journal article
Adherence patterns to cardiovascular medications in people with type 2 diabetes mellitus: a retrospective cohort study using group-based trajectory analysis in primary care
DOI: 10.1016/j.diabres.2025.1124092025
Journal article
Individual, Social and Environmental Factors Influencing Medication-Taking Among Adults of Vietnamese Heritage With Type 2 Diabetes Living in Australia: A Qualitative Study
DOI: 10.1016/j.clinthera.2025.01.0122025
Conference Proceedings
The impact of modified Pharmaceutical Benefits Scheme (PBS) prescribing restrictions on glucagon-like peptide-1 receptor agonists (GLP-1RAs) prescriptions in patients with type 2 diabetes
2024
Journal article
Utilization and cost of non-insulin glucose-lowering drugs in Australia from 2013 to 2023
DOI: 10.1111/dom.15893